CLASS II ONGOING Drug recall · Reported 15 Oct 2025 · FDA Enforcement Report

Succinylcholine Chloride Injection, USP, 200 mg/ (20 mg/mL) recalled

Dr. Reddy's Laboratories is recalling Succinylcholine Chloride Injection, USP, 200 mg/ (20 mg/mL), mL Multiple-Dose Vials, For, distributed nationwide in the US. The recall was initiated on 26 Sep 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # K250048
NDC43598-666
UPC0343598666259, 0343598666112
Quantity recalled571 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0008-2026
FDA event ID
97690
Recalling firm
Dr. Reddy's Laboratories, Princeton, NJ
Manufacturer
Dr.Reddy's Laboratories Inc.,
Classification
Class II
Status
Ongoing
Recall initiated
26 Sep 2025
FDA classified
7 Oct 2025
Reported
15 Oct 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

26 Sep 2025Recall initiated by company
7 Oct 2025Classified by FDA+11 days
15 Oct 2025Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, For Intravenous or Intramuscular use, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540. NDC: 43598-666-25

Where it was distributed

Nationwide within the USA.

Nationwide

Questions about this recall

Why was it recalled?

Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.

Which lots are affected?

Lot # K250048

Where was it sold?

Nationwide within the USA.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Dr. Reddy's Laboratories

All 165

Other Succinylcholine recalls

All 7